Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels
Crossref DOI link: https://doi.org/10.1007/s00262-014-1620-1
Published Online: 2014-10-16
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vihinen, Pia
Tervahartiala, Taina
Sorsa, Timo
Hansson, Johan
Bastholt, Lars
Aamdal, Steinar
Stierner, Ulrika
Pyrhönen, Seppo
Syrjänen, Kari
Lundin, Johan
Hernberg, Micaela
Text and Data Mining valid from 2014-10-16